$12,316.61 consulting Payment -- Boehringer Ingelheim to Dr. Daniel White
This page provides a detailed analysis of a $12,316.61 consulting payment from Boehringer Ingelheim to Dr. Daniel White. Data is from the CMS Open Payments (Sunshine Act) database.
Payment Details
| Field | Value |
|---|---|
| Amount | $12,316.61 |
| Payment Type | consulting |
| Payment Nature | Consulting Fee |
| Pharmaceutical Company | Boehringer Ingelheim |
| Physician | Dr. Daniel White |
| NPI Number | 1636761445 |
| Physician Specialty | Rheumatology |
| Location | New York, NY |
| Date of Payment | 2024-08-20 |
| Related Drug/Device | Keytruda |
Understanding consulting Payments
Consulting payments are made when pharmaceutical companies hire physicians as advisors or consultants. This can include serving on advisory boards, providing expert medical opinions on drug development or marketing strategies, and reviewing clinical data. Consulting is one of the most common forms of pharmaceutical payment to physicians and can range from a few hundred dollars for a brief consultation to tens of thousands of dollars for ongoing advisory relationships.
Related Reports
Data from CMS Open Payments (Sunshine Act). Payment does not imply wrongdoing. AI analysis is not medical or legal advice. Consult your healthcare provider about any concerns.